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gastroenteritis. Despite the absence of 
known pathogens among 6 of 7 BuVs-
shedding patients, the causative role of 
BuV in gastroenteritis remains uncer-
tain. Serologic studies will help clarify 
a possible association between BuVs 
and diarrhea or other diseases.
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Human  
Granulocytic  
Anaplasmosis  
Acquired in  
Scotland, 2013
To the Editor: Human granu-
locytic anaplasmosis is a tick-borne 
disease caused by Anaplasma phago-
cytophilum, an obligate intracellular 
gram-negative bacterium that infects 
granulocytes. The usual clinical signs 
and symptoms include nonspecific 
fever, chills, headache, and myalgia. 
Infection is usually mild or asymp-
tomatic, but severe systemic compli-
cations can occur, leading to a need for 
intensive care and estimated fatality 
rates of 0.5%–1.0% (1,2).
A. phagocytophilum was first 
described in 1932 in Scotland as the 
causative agent of tick-borne fever in 
sheep (3). Although some clinical cases 
of human granulocytic anaplasmosis 
have been reported in Europe, mostly 
from Slovenia, Sweden, and Poland 
(4), most cases have occurred in the 
United States. This difference cannot 
be explained by the prevalence of the 
pathogen in ticks or human exposure 
to the pathogen because the 3% preva-
lence of A. phagocytophilum among 
Ixodes ricinus ticks in Europe seems to 
be nearly as high as that among ticks in 
the United States (2). The median se-
roprevalence rate for A. phagocytophi-
lum infection among humans in Europe 
is 6.2%, reaching up to 21% (2). This 
incongruence between seroprevalence 
rate and number of human cases might 
be associated with underdiagnosis of 
cases (2), a high rate of asymptomatic 
disease (5), or cross-reactivities in se-
rologic tests that might lead to overesti-
mation of seroprevalence rate (5).
In August 2013, an immuno-
competent 40-year-old man sought 
treatment for fever (≈39°C) and other 
nonspecific symptoms such as mal-
aise, myalgia, and severe headache 3 
days after becoming aware of several 
tick bites received while on a hiking 
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vacation in Scotland. The man had 
removed the 3 tick nymphs from his 
legs immediately after their discovery 
and stored them in a plastic container; 
they were later sent to the Consultant 
Laboratory for Tick-borne Encepha-
litis in Berlin, Germany, for analysis. 
When the patient returned to Germa-
ny, 5 days after the onset of symptoms 
and 8 days after tick removal, a blood 
sample was collected (sample 1) and 
the bite sites were swabbed with a 
sterile cotton bud. By that time, the 
fever was gone, but malaise and other 
symptoms persisted. The patient be-
gan taking doxycycline, and within 2 
days all symptoms subsided and the 
patient recovered completely.
A second blood sample was col-
lected 28 days after tick removal (sam-
ple 2). Complete blood counts and 
chemistry panels were performed for 
both samples. All values were within 
the reference range except that for lac-
tate dehydrogenase (248 U/L), which 
was moderately increased over the 
baseline value of <245 U/L in sample 
1. Values did not differ substantially 
between the 2 samples.
DNA from whole-blood samples 
and swabs was extracted (QIAamp 
DNA Blood Mini Kit; QIAGEN, 
Hilden, Germany) and tested for A. 
phagocytophilum, Babesia spp., Bor-
relia spp., and Rickettsia spp. by using 
commercially available rapidSTRIPE 
assays for Anaplasma, Babesia, Bor-
relia, Rickettsia (all Analytik Jena AG; 
Jena, Germany). DNA extracted from 
blood and swab samples was negative 
for all tested pathogens.
After the tick specimens were 
taxonomically identified as I. ricinus, 
DNA/RNA was extracted (blackPREP 
Tick DNA/RNA Kit; Analytik Jena 
AG) and tested for the same patho-
gens. All 3 ticks were negative for 
Babesia spp., Borrelia spp., and Rick-
ettsia spp., but 2 were positive for A. 
phagocytophilum. 
Indirect immunofluorescence as-
says (Focus Diagnostics, Cypress, 
CA, USA) performed on the paired 
serum samples revealed an increased 
A. phagocytophilum–specific IgM ti-
ter, from 20 at 5 days after symptom 
onset to 80 at 20 days later; the A. 
phagocytophilum–specific IgG titer 
rose from a high titer of 800 to >3,200 
over this period.
The presence and 4-fold increase 
of A. phagocytophilum–specific IgM 
and IgG in paired serum samples con-
firmed the diagnosis of human granu-
locytic anaplasmosis in accordance 
with Centers for Disease Control and 
Prevention criteria (6). As described 
previously for several cases of human 
granulocytic anaplasmosis, patient 
blood counts were within reference 
limits but serum lactate dehydrogenase 
level was elevated (7). The diagnosis 
was further corroborated by detection 
of A. phagocytophilum DNA in 2 of 
the 3 ticks removed from the patient’s 
skin. PCR amplification failed to de-
tect A. phagocytophilum DNA in the 
patient’s blood, consistent with previ-
ous studies documenting frequent lack 
of A. phagocytophilum DNA detection 
in whole blood and a substantial drop 
in PCR positivity after the acute phase 
of illness (8).
Human granulocytic anaplasmo-
sis is not usually reported in Scotland 
like it is in the rest of Europe. The case 
originated from an area with long-es-
tablished disease occurrence in rumi-
nants, but the literature reports only 1 
case of human infection in southwest-
ern Scotland (9), ≈500 km from where 
this infection was probably acquired. 
Correct diagnosis would have been 
difficult had the patient not conserved 
the ticks and contacted the Consultant 
Laboratory for Tick-borne Encephali-
tis immediately after returning to Ger-
many. A large number of human gran-
ulocytic anaplasmosis cases might be 
missed because general practitioners 
may not be aware of the pathogen’s 
existence or its distribution.
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Genetic  
Relatedness of  
Dolphin  
Rhabdovirus with 
Fish Rhabdoviruses
To the Editor: Rhabdoviruses 
are enveloped, single-stranded, nega-
tive-sense RNA viruses that comprise 
a large and diverse family in the or-
der Mononegavirales and infect ar-
thropods, plants, fish, and mammals. 
There are 9 genera of rhabdoviruses: 
Cytorhabdovirus, Ephemerovirus, Lys-
savirus, Novirhabdovirus, Nucleorhab-
dovirus, Perhabdovirus, Sigmavirus, 
Tibrovirus, and Vesiculovirus. In addi-
tion, a substantial number of plant, ver-
tebrate, and invertebrate rhabdoviruses 
have not been classified (1). Three gen-
era (Novirhabdovirus, Perhabdovirus, 
and Vesiculovirus) comprise members 
that infect fresh water and marine fish 
(2). Fish rhabdoviruses pose a serious 
problem for aquaculture because of 
worldwide outbreaks of disease caused 
by novirhabdoviruses, perhabdovirus-
es, and vesiculoviruses (3,4).
In 1992, a rhabdovirus-like virus 
was isolated from lung and kidney of 
a white-beaked dolphin (Lagenorhyn-
chus albirostris) that had beached 
along the coast of the Netherlands 
(5). Although no macroscopic or mi-
croscopic lesions were observed at 
necropsy, negative contrast electron 
microscopy showed typical rhabdo-
virus-like, bullet-shaped particles in 
Vero cell cultures that showed a fo-
cal cytopathic effect (5). After this 
rhabdovirus-like virus was injected 
intracerebrally into brains of 1-day-
old suckling mice, they died within 
5 days (5). We report genetic and 
phylogenetic characterization of a 
dolphin rhabdovirus (DRV) and eval-
uated the seroprevalence of DRV-
neutralizing antibodies by using se-
rum samples from various marine 
mammals collected during a 10-year 
period (2003–2012).
To characterize DRV, we per-
formed random sequence amplifica-
tion and deep sequencing with the 454 
GS Junior Instrument (Roche, Basel, 
Switzerland) with DRV-infected Vero 
cell supernatants as described (6). 
From this analysis, we determined the 
complete coding sequence of DRV 
covered by 42,080 of 49,292 reads 
(minimum coverage 4 reads, average 
coverage 872 reads).
Genomic termini of DRV were 
determined by using a 3′ and 5′ rapid 
amplification of cDNA ends PCR 
and Sanger sequencing of obtained 
PCR amplicons. The complete ge-
nome of DRV (GenBank accession 
no. KF958252) consists of 11,141 
nt and has a typical rhabdovirus 
gene arrangement of 5 major open 
reading frames (ORFs) in the order 
3′-nucleoprotein (N), phosphoprotein 
(P), matrix (M) protein, glycoprotein 
(G), and large (L) protein-5′ (Figure, 
panel A, Appendix, wwwnc.cdc.gov/
EID/article/20/6/13-1880-F1.htm). 
No additional ORFs ≥300 nt were 
detected. Between the major ORFs 
of DRV, intergenic sequences were 
present that ranged in size from 34 
(P–M) to 83 (G–L) nucleotides. Pu-
tative transcription initiation and 
transcription termination polyadenyl-
ation sequences were AACA(G/U) 
and AUGA
7
, respectively.
The deduced amino acid se-
quence of genes of DRV and several 
other rhabdoviruses were aligned by 
using MUSCLE in MEGA5 version 
5.2) (7). Ambiguous aligned regions 
were removed by using the Gblocks 
program (8). Phylogenetic analysis 
of the L and G genes was performed 
by using the neighbor-joining method 
in MEGA5 (7). This analysis showed 
that DRV is most closely related to 
fish rhabdoviruses of the genera Per-
habdovirus and Vesiculovirus and 
unassigned fish rhabdoviruses with 
strong bootstrap support (Figure, 
panels B–D, Appendix).
Deduced amino acid sequences 
of the 5 major genes had the high-
est, although weak, homology with 
those of various fish rhabdoviruses by 
pairwise identity analyses: N (48%) 
with hybrid snakehead virus (HSHV), 
Monopterus albus rhabdovirus 
(MARV), and Siniperca chautsi rhab-
dovirus (SCRV); P (18%–20%) with 
eel virus European X (EVEX), HSHV, 
MARV, and SCRV; M (27%–33%) 
with lake trout rhabdovirus, Swedish 
sea trout rhabdovirus, and EVEX; G 
(30%–32%) with perch rhabdovirus, 
lake trout rhabdovirus, Swedish sea 
trout rhabdovirus, HSHV, MARV, 
SCRV, and EVEX; and L (54%–56%) 
with perch rhabdovirus, HSHV, and 
EVEX. This close relationship with 
fish rhabdoviruses is surprising be-
cause DRV was isolated from tissues 
of a mammal and propagated in mam-
malian cell lines at 37°C, which does 
not occur with related viruses isolated 
from fish.
To evaluate whether DRV or re-
lated viruses circulate among species 
of cetaceans, we performed serologic 
screening by using a virus neutraliza-
tion assay as described (5). The speci-
ficity of this assay was tested by using 
a panel of rhabdovirus-specific anti-
sera obtained from cetaceans of vari-
ous species (5). The serum samples 
had been collected for diagnostic pur-
poses from mainly juvenile cetaceans 
stranded along the coast of the Neth-
erlands during 2003–2012. These spe-
cies included 2 Atlantic white-sided 
dolphins (Lagenorhynchus acutus), 
79 harbor porpoises (Phocoena pho-
coena), 9 striped dolphins (Stenella 
